The Committee for Medicinal Products for Human Use is expected to adopt a formal decision on AB Science's masitinib when it ...
Increasing levels of the MIF protein slowed disease progression and prolonged survival in a mouse model of ALS, a study found ...
The ALS Association said it selected InnoVision as its agency of record for media and ALS awareness campaigns.
Spinogenix said the FDA cleared a Phase 1/2 clinical trial in the U.S. to test small molecule SPG302 in ALS patients.
With ALS in the picture, special events aren't taken for granted. Columnist Kristin Neva writes about her daughter's high school graduation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results